Comments
Commented by André Will-Laudien on September 3rd, 2024 | 07:30 CEST
Artificial intelligence as a winning model! 200% return with Super Micro Computer and BlockchainK2, Caution with Intel and Aixtron!
The high-tech wave has been quite pronounced so far in 2024. Even the correction in July had little impact on the strong trend, which is now continuing upward. However, investors now clearly differentiate between the business models. Pure hardware manufacturers like Intel and Aixtron are coming under increasing scrutiny. On the other hand, Nvidia, the industry leader, is now earning just as much money with data centers as with its ultra-fast graphics chips. In the small-cap segment, highly interesting companies are already successfully using artificial intelligence to streamline business processes and thus achieve enormous cost savings. We analyze a little deeper and look to identify the yield drivers.
Read
Commented by Stefan Feulner on September 3rd, 2024 | 07:00 CEST
AMD, VCI Global, Dell - The AI favorites after Nvidia
The event of the past trading week was chip giant Nvidia's quarterly figures. Once again, the US giant exceeded expectations. Nevertheless, investors were disappointed, as expectations were too high. Following the exaggerated share price rally of recent months, quite a few experts are advising investors to focus on AI companies with more favorable valuations. In addition to established corporations, smaller companies stand out, particularly those with innovative business areas that could experience a similar upward trend.
Read
Commented by André Will-Laudien on September 2nd, 2024 | 07:30 CEST
DAX on a high, clear turnaround at Evotec and Saturn Oil + Gas, TUI and Lufthansa in a daily battle
The current stock market euphoria might seem out of place at first glance, given the geopolitical uncertainties, sluggish economic growth, and persistent inflation. However, it is important to remember: The stock market is looking 6 to 9 months ahead. The expectation is that inflation will weaken significantly, and the current interest rate level will fall considerably. In this environment of "steadily improving conditions", technology shares seem to be on the rise. Wars such as those in Ukraine or the Middle East may weigh on people's minds, but they boost the balance sheets of the defense industry. In this respect, there is little reason for pessimism, and the DAX at least reached new all-time highs at the end of August. It is worth taking a look at some of the lagging stocks.
Read
Commented by Stefan Feulner on September 2nd, 2024 | 07:15 CEST
PayPal, Desert Gold Ventures, and Nel ASA facing decisive milestones
Despite fears of recession and increasing geopolitical tensions, Germany's leading index, the DAX, and the Dow Jones reached historic highs and generated fresh buy signals. The precious metal gold is also unstoppable and, after a brief breather, is once again targeting the USD 2,531 per ounce mark. The smaller gold producers and exploration companies, which have so far hardly been able to capitalize on the strong rise, should also benefit disproportionately from a longer bull run.
Read
Commented by Armin Schulz on September 2nd, 2024 | 07:00 CEST
Almonty Industries, Rheinmetall, Intel - The invisible engine of high-tech applications is called tungsten!
Tungsten, often operating behind the scenes, plays a central role in some of the most innovative and technologically sophisticated industries in the world. As a high-tech raw material, tungsten is essential for the production of modern microchips and electronic devices that shape our everyday lives. At the same time, it is an indispensable component in the defense industry, where its exceptional hardness and resilience contribute significantly to the development of advanced weapons systems. Due to its properties, tungsten is also being used increasingly in batteries. Nevertheless, the importance of this critical raw material is often underestimated.
Read
Commented by Fabian Lorenz on August 29th, 2024 | 07:00 CEST
Up to 200% upside potential! Evotec, Tui, and Almonty Industries shares!
Will Evotec's share price double or fall by 40%? Analyst opinions on the ailing biotech company differ widely. The management offers some encouragement, as insiders have been buying shares of Evotec. Almonty is currently performing strongly. The shares of the tungsten producer are at a yearly high. The half-year figures have been convincing, and analysts see around 200% upside potential. Has the share finally initiated its revaluation? By contrast, experts remain skeptical about Tui. Business is booming, but for how much longer?
Read
Commented by Fabian Lorenz on August 28th, 2024 | 07:30 CEST
Share buyback and buy recommendation! Rheinmetall, Aixtron, Saturn Oil + Gas share
Rheinmetall shares well above EUR 600? At least, that is what analysts believe. However, the share of the armaments group is currently struggling somewhat after reaching an all-time high of over EUR 560. But if Rheinmetall now also conquers space, new record highs should only be a matter of time. Analysts believe Saturn Oil & Gas shares have almost 200% upside potential. The oil company, with a market capitalization of over CAD 500 million, is increasingly becoming a free cash flow monster and now plans to use this for share buybacks. Analysts are also taking a positive view of Aixtron again. The technology company confirmed its forecast at an investor conference. How far can the share rise?
Read
Commented by Stefan Feulner on August 28th, 2024 | 07:15 CEST
Siemens Healthineers, Vidac Pharma, Viking Therapeutics - Powerful movements
After the hype during the COVID-19 pandemic, biotech stocks have lagged behind the broader market, allowing major technology companies to take the lead. Smaller, capital-intensive companies, in particular, have suffered from the high interest rate level. However, this is likely to change soon. On the one hand, monetary policy is expected to be eased, and on the other hand, demographic changes point to a long-term explosion in demand for new medications.
Read
Commented by André Will-Laudien on August 28th, 2024 | 07:00 CEST
Starting signal for a rally? BioNTech, Pfizer, and Bayer under scrutiny, Major news expected from Cardiol Therapeutics and Evotec
Despite all the prophecies of doom, life goes on in the biotech sector. With a medium-term focus, it makes sense to bet on management qualities, as the recent price drops were partially too severe, but the research approaches promise a better future. BioNTech and Pfizer still have to deal with the COVID-19 issue, while Bayer has now taken all measures to achieve a turnaround. The situation at Cardiol Therapeutics and Evotec is particularly interesting, as the members of the Management Board continue to buy shares regularly.
Read
Commented by Stefan Feulner on August 26th, 2024 | 07:30 CEST
BYD, Altech Advanced Materials, Xiaomi - Battle for the gold of the energy transition
The energy transition is underway, and demand for electric vehicles is increasing, albeit more slowly than expected. Lithium has so far been fundamental to the electrification of transportation. To minimize dependence on China, which controls a large part of the mining and processing of the rare metal, the European Union is turning to Serbia, where considerable deposits for battery production lie dormant. However, in addition to lithium-ion batteries, there are alternatives "Made in Germany" that could set the future standard.
Read